These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1679057)

  • 21. Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.
    Gelber C; Plaksin D; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1989 May; 49(9):2366-73. PubMed ID: 2784997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes.
    Maziarz R; Allen H; Strominger JL; Flavell R; Biro PA; Burakoff SJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6276-80. PubMed ID: 3875858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectors.
    Ballinari D; Grazioli L; Sensi ML; Borrello MG; Parmiani G
    Int J Cancer; 1985 Nov; 36(5):617-22. PubMed ID: 3877002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.
    Fallarino F; Ashikari A; Boon T; Gajewski TF
    Int Immunol; 1997 Sep; 9(9):1259-69. PubMed ID: 9310829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour, GR9.
    Garrido ML; Pérez M; Delgado C; Rojano J; Algarra I; Garrido A; Garrido F
    J Immunogenet; 1986; 13(2-3):159-67. PubMed ID: 3819450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward a genetic analysis of tumor rejection antigens.
    Boon T
    Adv Cancer Res; 1992; 58():177-210. PubMed ID: 1546558
    [No Abstract]   [Full Text] [Related]  

  • 28. Histocompatibility antigens on murine tumors.
    Goodenow RS; Vogel JM; Linsk RL
    Science; 1985 Nov; 230(4727):777-83. PubMed ID: 2997918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
    Li M; Muller J; Xu F; Hearing VJ; Gorelik E
    Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
    Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
    Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
    Grohmann U; Ullrich SJ; Mage MG; Appella E; Fioretti MC; Puccetti P; Romani L
    Eur J Immunol; 1990 Mar; 20(3):629-36. PubMed ID: 2318253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer.
    Stauss HJ; Van Waes C; Fink MA; Starr B; Schreiber H
    J Exp Med; 1986 Nov; 164(5):1516-30. PubMed ID: 3490532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo.
    Romani L; Puccetti P; Fioretti MC; Mage MG
    Int J Cancer; 1985 Aug; 36(2):225-31. PubMed ID: 3894248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K.
    Schmidt W; Leben L; Atfield G; Festenstein H
    Immunogenetics; 1981; 14(3-4):323-39. PubMed ID: 7333657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level.
    Grohmann U; Puccetti P; Romani L; Binaglia L; Bianchi R; Belladonna ML; Ullrich SJ; Appella E; Fioretti MC
    Int J Cancer; 1992 Sep; 52(3):372-7. PubMed ID: 1399112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
    Mandelboim O; Feldman M; Eisenbach L
    J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice.
    Zaloudik J; Li W; Jacob L; Kieny MP; Somasundaram R; Acres B; Song H; Zhang T; Li J; Herlyn D
    Cancer Gene Ther; 2002 Apr; 9(4):382-9. PubMed ID: 11960289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.